Isatuximab-Irfc is a medication that is used in the treatment of multiple myeloma, a type of cancer that affects plasma cells in the bone marrow. This drug works by targeting a specific protein on the surface of myeloma cells, which helps to slow down the growth and spread of the cancer.
Isatuximab-Irfc is typically used in combination with other medications, such as pomalidomide and dexamethasone, for patients who have already received at least two prior therapies. It is administered intravenously by a healthcare professional in a medical setting.
As with any medication, Isatuximab-Irfc may cause side effects. Common side effects may include fatigue, diarrhea, upper respiratory tract infections, and infusion-related reactions. It is important to discuss any concerns or side effects with your healthcare provider.
It is important to follow your healthcare provider’s instructions carefully when taking Isatuximab-Irfc. This medication has been shown to be effective in treating multiple myeloma, but it is important to continue with regular check-ups and monitoring to ensure that the treatment is working as intended.
If you have any questions or concerns about Isatuximab-Irfc or any other medications you are taking, do not hesitate to speak with your healthcare provider. They can provide you with more information about the drug, its potential side effects, and how it may benefit you in your treatment plan.
EN 
ES 
FR 
PT 
ZH